Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sigal Elliot
Relationship:   Director
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   148,221    

Indirect Shares

   78,638      
Direct Value   $6,188,227    

Indirect Value

   $5,549,704      
Total Shares   226,859      
Total Value   $11,737,931      


Bristol-Myers Squibb Co $6,188,227 Bristol-Myers Squibb Co $6,188,227
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Bristol-Myers Squibb Co BMY EVP, CSO & President R... 2013-06-03 148,221 2013-06-03 47,079    Premium*  
            Mead Johnson Nutrition Co MJN Director 2017-06-15 0 2017-06-15 0    Premium*  
            Spark Therapeutics, Inc. ONCE Director 2019-12-17 0 2015-02-04 31,559    Premium*  
* Premium Members only  

Records found :    133         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       –      –    2008-09-19 4 D $21.00 $162,582 D/D (7,742) 153,879 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       –      –    2009-09-21 4 D $22.52 $174,350 D/D (7,742) 170,634 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-01 4 D $32.64 $176,648 D/D (5,412) 215,377 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       –      –    2010-09-20 4 D $27.81 $214,860 D/D (7,726) 134,496 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-02 4 D $32.59 $240,612 D/D (7,383) 223,922 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       –      –    2009-02-19 4/A D $20.51 $273,439 D/D (13,332) 169,247 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       –      –    2009-04-30 4 B $19.18 $287,700 D/D 15,000 178,376 2.74 -
BMY Bristol-Myers Squibb Co CSO & President PRI   •       –      –    2006-03-07 4 A $22.73 $638,872 D/D 28,107 188,046 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-03 4 D $32.59 $700,392 D/D (21,491) 248,796 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-03-03 4 D $37.15 $893,123 D/D (24,041) 111,753 0 -
MJN Mead Johnson Nutrition Co Director   –       •      –    2017-06-15 4 D $90.00 $1,165,500 I/I (12,950) 0 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       –      –    2010-03-15 4 S $25.94 $1,233,784 D/D (47,563) 142,222 0 -
MJN Mead Johnson Nutrition Co Director   –       •      –    2017-06-15 4 D $90.00 $1,234,890 D/D (13,721) 0 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-03-06 4 D $32.33 $1,286,217 D/D (39,784) 298,840 0 -
ONCE Spark Therapeutics, Inc. Director   –       •      –    2019-12-17 4 D $114.50 $1,627,503 D/D (14,214) 0 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-04-29 4 OE $22.73 $1,763,821 D/D 73,390 258,411 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-04-29 4 S $39.97 $1,829,947 I/I (45,783) 9,550 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-05-16 4 S $28.90 $2,046,265 D/D (70,805) 372,572 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-06-03 4 OE $27.01 $2,670,614 D/D 98,875 231,868 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-03-07 4 D $37.53 $2,816,214 D/D (75,039) 185,021 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-06-03 4 S $48.18 $4,030,112 D/D (83,647) 148,221 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-04-29 4 S $39.90 $4,188,026 D/D (104,918) 153,493 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2011-05-18 4 D $28.70 $4,313,747 D/D (150,299) 205,902 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2013-05-30 4 OE $24.74 $4,495,081 D/D 170,625 276,514 0 -
BMY Bristol-Myers Squibb Co EVP, CSO & President R&D   •       •      –    2012-12-11 4 S $33.00 $5,189,481 I/I (157,257) 37,412 0 -
  133  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us